4th Quarter - Report

REVVITY, INC. for REVVITY, INC.

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses

LobbyistCovered position, as disclosed
JORDAN COX Sr. Advisor, Office of the Asst Secretary for Legislation, US Dept. of Health & Human Services, Sr. Legislative Asst, US Representative Vicky Hartzler, Legislative Aide, US Senator Deb Fischer, Legislative Aide, US Representative John R. Carter

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6102 (118th), H.R. 8882 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.